Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Ahlfors UG, Baastrup PC, Dencker SJ et al. (1981) Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium. Acta Psychiat Scand 64:226–237
Angst J (1980) Verlauf unipolar depressiver, bipolar manisch-depressiver und schizo-affektiver Erkrankungen und Psychosen. Ergebnis einer prospektiven Studie. Fortschr Neurol Psychiat 48:3–30
Angst J (1981 a) Ungelöste Probleme bei der Indikationsstellung zur Lithiumprophylaxe affektiver und schizoaffektiver Erkrankungen. Biblthca psychiat 161. Karger, Basel, S. 34–44
Angst J (1981b) Clinical indications for a prophylactic treatment of depression. Adv Biol Psychiat 7:218–229
Angst J, Müller-Oerlinghausen B (1980) Methodische Anmerkungen zur Langzeitbehandlung mit Lithium. Pharmacopsychiat 13:152–155
Angst J, Weis P, Grof P, Baastrup C, Schou M (1970) Lithium prophylaxis in recurrent affective disorders. Brit J Psychiat 116:604–614
Baastrup PC (1964) The use of lithium in manic-depressiv psychosis. Compr Psychiat 5:396–408
Baastrup PC, Schou M (1967) Lithium as a prophylactic agent. Its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiat 16:162–172
Baastrup PC, Poulsen JC, Schou M, Thomsen K, Amdisen A (1970) Prophylactic lithium: Double blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 2:326–330
Blackwell B, Shepherd M (1968) Prophylactic lithium: Another therapeutic myth? Lancet 1:968–971
Bunney WE (1978) Psychopharmacology of the switch process in affective illness. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: A generation of progress. Raven, New York, pp 1249–1259
Cade JFJ (1949) Lithium salts in the treatment of psychotic excitement. Med J Aust 36:349–352
Carroll BJ (1979) Prediction of treatment outcome with lithium. Arch Gen Psychiat 36:870–878
Cazzullo CL, Sacchetti E (1984) Critical issues in the evaluation of long-term lithium treatment. In: Corsini GU (ed) Current trends in lithium and rubidium therapy. MTP Press, Lancaster, pp 95–110
Coppen A, Noguera R, Bailey J et al. (1971) Prophylactic lithium in affective disorders. Lancet 2:275–279
Coppen A, Montgomery SA, Gupta RK, Bailey JE (1976) A double-blind comparison of lithium carbonate and maprotiline in the prophylaxis of the affective disorders. Brit J Psychiat 128:479–485
Coppen A, Ghose K, Montgomery S, Rama Rao VA, Bailey J, Jorgensen A (1978 a) Continuation therapy with amitriptyline in depression. Brit J Psychiat 133:28–33
Coppen A, Ghose K, Rao R, Bailey J, Peet M (1978 b) Mianserin and lithium in the prophylaxis of depression. Brit J Psychiat 133:206–210
Cundall RL, Brooks PW, Murray LG (1972) A controlled evaluation of lithium prophylaxis in affective disorders. Psychol Med 2:308–311
Davis JM (1976) Overview: Maintenance therapy in psychiatry: II. Affective disorders. Amer J Psychiat 133:1–13
Dunner DL, Stallone F, Fieve RR (1976) Lithium carbonate and affective disorders. V. A double-blind study of prophylaxis of depression in bipolar illness. Arch Gen Psychiat 33:117–120
Editorial (1969) Lithium. Lancet 1:709–710
Felber W (1979) Die rezidivprophylaktische Behandlung der Zyklothymie mit Lithium: Auswertung von 850 unter gemeinsamer Arbeitskonzeption 1968 bis 1973 vorgenommenen Lithium-Behandlungen in der DDR. Med. Dissertation, Universität Dresden
Felber W (1981) Rezidivprophylaxe affektiver Erkrankungen mit Lithium und ihre Auswirkungen. Psychiatria Clin 14:161–166
Felber W, König L, Lange E (1981) Rehabilitative Ziele in der Psychiatrie — Die Lithiumbehandlung affektiver Psychosen. Dt Gesundh Wesen 36:289–293
Glen AIM, Johnson AL, Shepherd M (1984) Continuation therapie with lithium and amitriptyline in unipolar depressive illness: A randomized, double-blind, controlled trial. Psychol Med 14:37–50
Greil W, Broucek B, Klein HE, Engel-Sittenfeld P (1982) Discontinuation of lithium maintenance therapy: Reversibility of clinical, psychological and neuroendocrinological changes. In: Emrich HM, Aldenhoff JB, Lux HD (eds) Basic mechanisms in the action of lithium. Excerpta Medica, Amsterdam Oxford Princeton, pp 235–248
Grof P, Schou M, Angst J, Baastrup PC, Weis P (1970) Methodological problems of prophylactic trials in recurrent affective disorders. Brit J Psychiat 116:599–619
Grof P, Angst J, Haines T (1974) The clinical course of depression: Practical issues. In: Angst A (ed) Classification and prediction of outcome of depression. Schattauer, Stuttgart New York, pp 141–148
Grof P, Hux M, Grof E, Arato M (1983) Prediction of response to stabilizing lithium treatment. Pharmacopsychiatria 16:195–200
Haag M, Haag H, Eisenried F, Greil W (1984) RBC-choline: Changes by lithium and relation to prophylactic response. Acta Psychiat Scand 70:389–399
Hartigan GP (1963) The use of lithium salts in affective disorders. Brit J Psychiat 109:810–814
Hofmann G, Grünberger J, König P, Presslich O, Wolf R (1974) Die mehrjährige Lithiumtherapie affektiver Störungen. Langzeiteffekte und Begleiterscheinungen. Psychiatria Clin 7:129–148
Hollister LE (ed) (1978) Clinical pharmacology of psychotherapeutic drugs. Churchill Livingstone, New York
Hullin RP, McDonald R, Allsopp MNE (1972) Prophylactic lithium in recurrent affective disorders. Lancet 1:1044–1046
Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Nayak DD, Howard A (1982) Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness. A prospektive, placebo-controlled comparison. Arch Gen Psychiat 39:1065–1069
Klein HE, Broucek B, Greil W (1981) Lithium withdrawal triggers psychotic states. Brit J Psychiat 139:255–256
Kraepelin E (Hrsg) (1909) Allgemeine Psychiatric Barth, Leipzig
Kukopulos A, Reginaldi D (1980) Recurrences of manic-depressive episodes during lithium treatment. In: Johnson FN (ed) Handbook of lithium therapy. MTP Press, Lancaster, pp 109–117
Lewis JL, Winokur G (1982) The induction of mania. Arch Gen Psychiat 39:303–306
Lundquist G (1945) Prognosis and course in manic-depressive psychoses. Acta Psychiat Neurol (Suppl) 35:1–96
Melia PI (1970) Prophylactic lithium: A double-blind trial in recurrent affective disorders. Brit J Psychiat 116:621–624
Mindham RHS, Howland C, Shepherd M (1973) An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychol Med 3:5–17
Noack CH, Trautner EM (1951) The lithium treatment of maniacal psychosis. Med J Aust 38:219–222
Perds C (1966) A study of bipolar (manic-depressive) and unipolar depressive psychoses. Acta Psychiat Scand (Suppl) 194:1–88
Perris C (1968) The course of depressive psychoses. Acta Psychiat Scand 44:238–248
Persson G (1972) Lithium prophylaxis in affective disorders. An open trial with matched controls. Acta Psychiat Scand 48:462–479
Pétursson H (1979) Prediction of lithium response. Compr Psychiat 20:226–241
Prien RF (1983) Long-term maintenance therapy in affective disorders. In: Rifkin A (ed) Schizophrenia and affective disorders. Wright, Boston Bristol London, pp 95–115
Prien RF, Caffey EM Jr, Klett J (1973 a) Prophylactic efficacy of lithium carbonate in manic depressive illness. Arch Gen Psychiat 28:337–341
Prien RF, Klett J, Caffey EM Jr (1973 b) Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Arch Gen Psychiat 29:420–425
Prien RF, Caffey EM, Klett J (1974) Factors associated with treatment success in lithium carbonate prophylaxis. Arch Gen Psychiat 31:189–192
Prien RF, Kupfer DJ, Mansky PA, Small JG, Tuason VB, Voss CB, Johnson WE (1984) Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Arch Gen Psychiat 41:1096–1104
Quitkin FM, Kane J, Rifkin A, Ramos-Lorenzi JR, Nayak DV (1981) Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study. Arch Gen Psychiat 38:902–907
Sarantidis D, Waters B (1981) Predictors of lithium prophylaxis effectiveness. Prog Neuro Psychopharmacol 5:507–510
Schou M (1971) Die Lithiumprophylaxe bei manisch-depressiven Psychosen. Nervenarzt 42:1–10
Schou M (1978) Lithium for affective disorders: Cost and benefit. In: Ayd FJ Jr, Taylor IJ (eds) Mood disorders: The world’s major public health problem. Ayd Medical, Baltimore, pp 117–137
Schou M, Juel-Nielsen N, Strömgren E, Voldby H (1954) The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiat 17:250–260
Seagar CP, Bird RL (1962) Imipramine with electrical treatment in depression — a controlled trial. J Ment Sci 108:704–707
Smigan L (1985) Long-term lithium treatment. Some clinical, psychological and biological aspects. Acta Psychiat Scand 71:160–170
Stallone F, Shelley E, Mendlewicz J, Fieve RR (1973) The use of lithium in affective disorders. III. A double-blind study of prophylaxis in bipolar illness. Amer J Psychiat 130:1006–1010
Stenstedt AC (1952) A study in manic-depressive psychosis. Acta Psychiat Scand (Suppl) 79:1–111
Tyrer SP, Shopsin B, Aronson M (1983) Dangers of reducing lithium. Brit J Psychiat 143:427 (letter)
Waters B, Lapierre Y, Gagnon A, Cahudry R, Tremblay A, Sarantidis D, Gray R (1982) Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorder. Biol. Psychiat 17:1323–1329
Zis AP, Goodwin FK (1979) Major affective disorders as a recurrent illness. Arch Gen Psychiat 36:835–839
Zis AP, Grof P, Goodwin FK (1979) The natural course of affective disorders: Implications for lithium prophylaxis. In: Cooper TB, Gershon S, Kline NS, Schou M (eds) Lithium: Controversies and unresolved issues. Excerpta Medica, Amsterdam Oxford Princeton, pp 381–398
Zis AP, Grof P, Webster MA, Goodwin FK (1980) Prediction of relapse in recurrent affective disorder. Psychopharmacol Bull 16:47–49
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Greil, W., Schölderle, M. (1986). Rezidivprophylaxe affektiver Psychosen mit Lithium. In: Müller-Oerlinghausen, B., Greil, W. (eds) Die Lithiumtherapie Nutzen, Risiken, Alternativen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-96935-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-96935-5_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-96936-2
Online ISBN: 978-3-642-96935-5
eBook Packages: Springer Book Archive